Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023
Vaccines · 05.02.2025 · 13 (2) · 157
DOI: 10.3390/vaccines13020157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 05.02.2025. Verfasst von Pedro Plans-Rubió. Beteiligte Einrichtung: College of Physicians of Barcelona, 08017 Barcelona, Spain. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The objectives of this study were as follows: to determine mean percentages of measles vaccination coverage with zero, one and two doses of vaccine and anti-measles herd immunity levels in World Health Organization (WHO) regions in 2023; to assess variations in measles vaccination coverage and anti-measles herd immunity-related indicators from 2019 to 2023; and to assess whether zero-dose measles vaccination coverage indicators were on track to achieve the Immunization Agenda 2030 objective.
Methods
Mean percentages of vaccination coverage with two, one and zero doses of measles vaccine in WHO regions in 2023 were calculated using data from the WHO/UNICEF global and regional immunization information system.
Results
In 2023, the global mean two-dose measles vaccination coverage was 65.3%, and mean two-dose vaccination coverage was lower than 95% in all WHO regions; the mean prevalence of measles-protected individuals in the target vaccination population was 87.6%, and anti-measles herd immunity levels in the target vaccination population were sufficient to block the transmission of measles viruses with greater transmissibility (Ro ≥ 15) only in the Western Pacific and European WHO regions. The global mean two-dose measles vaccination coverage decreased by 3.7% from 2019 to 2023. In 2023, the mean zero-dose measles coverage and number of zero-dose measles children were, respectively, 36.7% and 40.6% greater than the values required to be on track to achieve the 2030 objective.
Conclusion
This study found that all measles-vaccination-coverage-related indicators worsened from 2019 to 2023, and the zero-dose measles vaccination coverage and number of zero-dose measles children in 2023 were not on track to achieve the AI2030 objective. Interventions to increase routine two-dose measles vaccination coverage should be developed in all WHO regions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Physicians of Barcelona, 08017 Barcelona, Spain.
ORCID-Profile: Pedro Plans-Rubió
Zitieren
APA
Plans-Rubió, P. (2025). Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023. Vaccines, 13(2), 157. https://doi.org/10.3390/vaccines13020157
Vancouver
Plans-Rubió P. Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023. Vaccines. 2025;13(2):157. doi:10.3390/vaccines13020157
BibTeX
@article{PlansRubi2025,
author = {Plans-Rubió, Pedro},
title = {Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {2},
pages = {157},
doi = {10.3390/vaccines13020157}
}
EUVIMED